Literature DB >> 30865790

A Short Regimen for Rifampin-Resistant Tuberculosis.

Gavin J Churchyard1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30865790     DOI： 10.1056/NEJMe1902904

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  2 in total

Review 1.  Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin.

Authors:  Samantha Pillay; Karen R Steingart; Geraint R Davies; Marty Chaplin; Margaretha De Vos; Samuel G Schumacher; Rob Warren; Grant Theron
Journal:  Cochrane Database Syst Rev       Date:  2022-05-18

2.  Enhanced eradication of intracellular and biofilm-residing methicillin-resistant Staphylococcus aureus (MRSA) reservoirs with hybrid nanoparticles delivering rifampicin.

Authors:  Pengbo Guo; Hui Yi Xue; Bettina A Buttaro; Ngoc T Tran; Ho Lun Wong
Journal:  Int J Pharm       Date:  2020-08-30       Impact factor: 5.875
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.